# Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer

> **NCT01460186** · NA · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Cancer
- Metastasis

## Interventions

- **OTHER:** Blood sample for genetic analysis (Identification of germ line genetic factors that influence the risk of metastatic breast cancer)

## Key facts

- **NCT ID:** NCT01460186
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2017-09-01
- **Final completion:** 2017-09-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2019-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460186, "Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01460186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*